Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases

Huapeng Lin, Grace Lai-Hung Wong, Xinrong Zhang, Terry Cheuk-Fung Yip, Ken Liu, Yee Kit Tse, Vicki Wing-Ki Hui, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2022;28(1):77-90. Published online November 5, 2021

DOI: https://doi.org/10.3350/cmh.2021.0188

Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B

Lilian Yan Liang, Hye Won Lee, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip, Yee-Kit Tse, Vicki Wing-Ki Hui, Grace Chung-Yan Lui, Henry Lik-Yuen Chan, Grace Lai-Hung Wong

Clin Mol Hepatol. 2021;27(3):499-509. Published online February 26, 2021

Cited By 1

DOI: https://doi.org/10.3350/cmh.2020.0333

Review

Anti-fibrotic treatments for chronic liver diseases: The present and the future

Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada

Clin Mol Hepatol. 2021;27(3):413-424. Published online December 3, 2020

Cited By 1

DOI: https://doi.org/10.3350/cmh.2020.0187

Original Article

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B

Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

Clin Mol Hepatol. 2021;27(2):295-304. Published online December 3, 2020

Cited By 2

DOI: https://doi.org/10.3350/cmh.2020.0216

Editorial

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact

Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2021;27(2):273-277. Published online February 1, 2021

Cited By 2

DOI: https://doi.org/10.3350/cmh.2021.0019

Marta Tonon, Salvatore Piano

Clin Mol Hepatol. 2021;27(1):94-96. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0305

Review

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective

Gwyneth Soon, Aileen Wee

Clin Mol Hepatol. 2021;27(1):44-57. Published online November 19, 2020

Cited By 6

DOI: https://doi.org/10.3350/cmh.2020.0181

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Emerging medical therapies for severe alcoholic hepatitis

David Tornai, Gyongyi Szabo

Clin Mol Hepatol. 2020;26(4):686-696. Published online September 28, 2020

Cited By 1

DOI: https://doi.org/10.3350/cmh.2020.0145

Review

Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis

Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada

Clin Mol Hepatol. 2020;26(3):280-293. Published online June 4, 2020

Cited By 5

DOI: https://doi.org/10.3350/cmh.2020.0037

Original Article

Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients

Waleed Seif Eldin Mohamed Mostafa, Mohammed Hassan Saiem Al-Dahr, Dalia Abdel Hamid Omran, Zeinab Fathy Abdullah, Suzan Hamdy Elmasry, Mohamed Nabil Ibrahim

Clin Mol Hepatol. 2020;26(1):60-69. Published online October 22, 2019

Cited By 2

DOI: https://doi.org/10.3350/cmh.2019.0051

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection

Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim

Clin Mol Hepatol. 2020;26(1):33-44. Published online June 27, 2019

Cited By 7

DOI: https://doi.org/10.3350/cmh.2018.0073

Review

Advances in ultrasound diagnosis in chronic liver diseases

Hitoshi Maruyama, Naoya Kato

Clin Mol Hepatol. 2019;25(2):160-167. Published online February 18, 2019

Cited By 12

DOI: https://doi.org/10.3350/cmh.2018.1013

Original Article

The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study

Laura Rotundo, Alana Persaud, Mirela Feurdean, Sushil Ahlawat, Hyun-seok Kim

Clin Mol Hepatol. 2018;24(4):392-401. Published online August 2, 2018

Cited By 19

DOI: https://doi.org/10.3350/cmh.2018.0011

Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases

San Juan López Cristina, Casado Martín Marta, González Sánchez Mercedes, Porcel Martín Almudena, Hernández Martínez Álvaro, Vega Sáenz Jose Luis, Parrón Carreño Tesifón

Clin Mol Hepatol. 2018;24(4):384-391. Published online July 4, 2018

Cited By 8

DOI: https://doi.org/10.3350/cmh.2018.0004

Editorial

Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level

Mi Young Jeon, Beom Kyung Kim, Seung Up Kim

Clin Mol Hepatol. 2018;24(4):367-369. Published online September 19, 2018

Cited By 4

DOI: https://doi.org/10.3350/cmh.2018.1008

Review

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend

Grace Lai-Hung Wong

Clin Mol Hepatol. 2018;24(2):108-113. Published online January 22, 2018

Cited By 26

DOI: https://doi.org/10.3350/cmh.2017.0068

Histopathological evaluation of liver fibrosis and cirrhosis regression

Regina C. Lo, Haeryoung Kim

Clin Mol Hepatol. 2017;23(4):302-307. Published online December 20, 2017

Cited By 45

DOI: https://doi.org/10.3350/cmh.2017.0078

Liver Imaging

What we need to know when performing and interpreting US elastography

So Hyun Park, So Yeon Kim, Chong Hyun Suh, Seung Soo Lee, Kyoung Won Kim, So Jung Lee, Moon-Gyu Lee

Clin Mol Hepatol. 2016;22(3):406-414. Published online September 25, 2016

Cited By 32

DOI: https://doi.org/10.3350/cmh.2016.0106

Original Article

Magnetization-tagged MRI is a simple method for predicting liver fibrosis

Kyung-Eun Kim, Mi-Suk Park, Sohae Chung, Chansik An, Leon Axel, Rakhmonova Gulbahor Ergashovna

Clin Mol Hepatol. 2016;22(1):140-145. Published online March 28, 2016

Cited By 1

DOI: https://doi.org/10.3350/cmh.2016.22.1.140

Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis

Yoon Ok Jang, Baek Gyu Jun, Soon Koo Baik, Moon Young Kim, Sang Ok Kwon

Clin Mol Hepatol. 2015;21(2):141-149. Published online June 26, 2015

Cited By 36

DOI: https://doi.org/10.3350/cmh.2015.21.2.141

The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B

In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim

Clin Mol Hepatol. 2015;21(1):32-40. Published online March 25, 2015

Cited By 12

DOI: https://doi.org/10.3350/cmh.2015.21.1.32

Editorial

Regression of liver cirrhosis: Orthodoxy or paradigm shift?

Su Jong Yu

Clin Mol Hepatol. 2015;21(1):22-23. Published online March 25, 2015

Cited By 1

DOI: https://doi.org/10.3350/cmh.2015.21.1.22

Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD

Wonseok Kang, Seung Up Kim

Clin Mol Hepatol. 2013;19(3):255-257. Published online September 30, 2013

Cited By 2

DOI: https://doi.org/10.3350/cmh.2013.19.3.255

Original Article

The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis

Jong Ho Chung, Hyung Su Ahn, Sang Gyune Kim, Yun Nah Lee, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2013;19(2):156-164. Published online June 27, 2013

Cited By 24

DOI: https://doi.org/10.3350/cmh.2013.19.2.156

Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients

Hyun Seok Lee, Young Oh Kweon, Won Young Tak, Soo Young Park, Eun Jung Kang, Yu Lim Lee, Hae Min Yang, Hyun Woo Park

Clin Mol Hepatol. 2013;19(2):148-155. Published online June 27, 2013

Cited By 2

DOI: https://doi.org/10.3350/cmh.2013.19.2.148

Editorial

Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis

Goh Eun Chung, Donghee Kim

Clin Mol Hepatol. 2013;19(2):116-119. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.116

Review

Clinical applications of transient elastography

Kyu Sik Jung, Seung Up Kim

Clin Mol Hepatol. 2012;18(2):163-173. Published online June 26, 2012

Cited By 54

DOI: https://doi.org/10.3350/cmh.2012.18.2.163

NADPH oxidase mediated oxidative stress in hepatic fibrogenesis

Yong-Han Paik, David A. Brenner

Clin Mol Hepatol. 2011;17(4):251-257. Published online December 26, 2011

Cited By 31

DOI: https://doi.org/10.3350/kjhep.2011.17.4.251

Original Article

Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma

Su Jong Yu, Jeong-Hoon Lee, Goh Eun Chung, Chang-Hoon Lee, Eun Ju Cho, Eun Sun Jang, Min-Sun Kwak, Yoon Jun Kim, Jung-Hwan Yoon, Ja-June Jang, Hyo-Suk Lee

Clin Mol Hepatol. 2010;16(4):389-396. Published online December 31, 2010

Cited By 1

DOI: https://doi.org/10.3350/kjhep.2010.16.4.389

3

Factors associated with Liver stiffness in chronic Liver disease

Da Mi Lee, M.D., Eun Joon Moon, M.D., Joo An Hwang, M.D., Min Suk Lee, M.D., Jae Youn Cheong, M.D., Sung Won Cho, M.D., Yeong Bae Kim, M.D. Dong Joon Kim, M.D. Seong Gyu Hwang, M.D. Jin Mo Yang, M.D.

Clin Mol Hepatol. 2009;15(4):464-473. Published online December 31, 2009

Cited By 4

DOI: https://doi.org/10.3350/kjhep.2009.15.4.464

1 | 2 |

Viewed By 6553	Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
Viewed By 4076	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Viewed By 3035	Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
Viewed By 2737	Recent advances in nonalcoholic fatty liver disease metabolomics
Viewed By 2652	Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis

Cited By 36	Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
Cited By 29	Application of transient elastography in nonalcoholic fatty liver disease
Cited By 27	Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Cited By 22	Novel biomarkers for the management of chronic hepatitis B
Cited By 19	Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard

Search